207 related articles for article (PubMed ID: 36792010)
1. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.
Stammler R; Nguyen Y; Yelnik C; Le Guern V; Lambert M; Paule R; Hachulla E; Mouthon L; Dupré A; Ackermann F; Dufrost V; Wahl D; Godeau B; Leroux G; Benhamou Y; Lazaro E; Daugas E; Bezanahary H; Mekinian A; Piette JC; Morel N; Costedoat-Chalumeau N
J Thromb Haemost; 2023 May; 21(5):1258-1265. PubMed ID: 36792010
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Cohen H; Efthymiou M; Devreese KMJ
J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604
[TBL] [Abstract][Full Text] [Related]
3. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
5. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
Amoura Z; Bader-Meunier B; Bal Dit Sollier C; Belot A; Benhamou Y; Bezanahary H; Cohen F; Costedoat-Chalumeau N; Darnige L; Drouet L; Elefant E; Harroche A; Lambert M; Martin T; Martin-Toutain I; Mathian A; Mekinian A; Pineton De Chambrun M; de Pontual L; Wahl D; Yelnik C; Zuily S;
Rev Med Interne; 2023 Sep; 44(9):495-520. PubMed ID: 37735010
[TBL] [Abstract][Full Text] [Related]
6. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
Gu JY; Lu C; Shi H; Yang CD
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
[TBL] [Abstract][Full Text] [Related]
7. [Catastrophic antiphospholipid syndrome: diagnosis and treatment].
Reshetniak TM; Aleksandrova EN; Shtivel'band IB; Radenska-Lopovok SG
Ter Arkh; 2005; 77(5):41-7. PubMed ID: 15989002
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
[TBL] [Abstract][Full Text] [Related]
10. [Seronegative antiphospholipid syndrome, catastrophic syndrome, new anticoagulants: learning from a difficult case report].
Joalland F; de Boysson H; Darnige L; Johnson A; Jeanjean C; Cheze S; Augustin A; Auzary C; Geffray L
Rev Med Interne; 2014 Nov; 35(11):752-6. PubMed ID: 25217794
[TBL] [Abstract][Full Text] [Related]
11. Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
[TBL] [Abstract][Full Text] [Related]
12. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".
Berman H; Rodríguez-Pintó I; Cervera R; Gregory S; de Meis E; Rodrigues CE; Aikawa NE; de Carvalho JF; Springer J; Niedzwiecki M; Espinosa G;
Autoimmun Rev; 2014 Feb; 13(2):157-62. PubMed ID: 24145009
[TBL] [Abstract][Full Text] [Related]
13. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).
Agmon-Levin N; Rosário C; Katz BS; Zandman-Goddard G; Meroni P; Cervera R; Stojanovich L; Blank M; Pierangeli S; Praprotnik S; Meis Ed; Seguro LP; Ruffatti A; Pengo V; Tincani A; Doria A; Shoenfeld Y
Lupus; 2013 Nov; 22(13):1327-35. PubMed ID: 24036580
[TBL] [Abstract][Full Text] [Related]
14. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
Cohen H; Isenberg DA
Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.
Dupré A; Morel N; Yelnik C; Moguelet P; Le Guern V; Stammler R; Nguyen Y; Paule R; Dufrost V; Ackermann F; Benhamou Y; Godeau B; Lambert M; Duffau P; Mekinian A; Saadoun D; Mouthon L; Hachulla E; Maillard H; Levesque H; Morell-Dubois S; Leroux G; Piette JC; Chasset F; Costedoat-Chalumeau N
JAMA Dermatol; 2023 Jan; 159(1):62-67. PubMed ID: 36477813
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
[TBL] [Abstract][Full Text] [Related]
18. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.
Rymarz A; Niemczyk S
BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Plasma Exchange in Catastrophic Antiphospholipid Syndrome (CAPS): A Rare Case Report and Literature Review.
Bereanu AS; Pisaltu T; Bereanu R; Vintila B; Codru I; Chicea L; Crisan O; Căinap C; Cainap S; Sava M
In Vivo; 2023; 37(4):1914-1919. PubMed ID: 37369472
[TBL] [Abstract][Full Text] [Related]
20. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review.
Escoda T; George J; Jarrot PA; Jean R; Mazodier K; Sanderson F; Poullin P; Saby L; Jourde-Chiche N; Kaplanski G; Chiche L
Lupus; 2022 May; 31(6):744-753. PubMed ID: 35341372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
